Cartesian Growth Corporation III
NASDAQ:CGCTShell Companies
-$1.91 today
- Market cap
- $328.44M
- Beta
- 0.51
- P/E (TTM)
- 66.9
- EPS (TTM)
- $0.23
Volume 0.34M
Average 0.21M
CGCT Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Cartesian Growth Corporation IIINASDAQ: CGCT
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock rises 41430289.0% from a year ago
Common stock stood at $285.87M at the end of Q1 FY2026, up 41430289.0% from a year earlier and up 0.9% from the prior quarter.
Context
- Common stock amounted to 99.8% of total assets at the end of Q1 FY2026, up 99.7 pp from a year earlier.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +41430289.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 283.38M USD
- Year-over-year change
- +49283024.5%
- 1-year CAGR
- +49283024.5%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 283.38M | +49283024.5% |
| FY2024 | 2024-12-31 | 575 | — |
Common Stock vs competitors
How CGCT compares with its peers on the latest reported figures
- CGCT's Mar 2026 common stock of $285.87M is the 2nd highest of the 9 companies compared; the peer median is $247.08M.
- Its year-over-year change of +41430289.0% is the highest of 9, against a peer median of +4.1%.
- Common stock amounts to 99.8% of total assets for CGCT, versus a peer median of 99.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
MBAVM3-Brigade Acquisition V Corp. Class A Ordinary shares | Mar 2026 | $309.58M | +4.0% | — | 99.7% |
| Mar 2026 | $285.87M | +41430289.0% | — | 99.8% | |
| Mar 2026 | $259.89M | +30828619.6% | — | 99.0% | |
| Mar 2026 | $249.9M | +41374287.6% | — | 99.7% | |
| Mar 2026 | $247.74M | +4.0% | — | 100.0% | |
POLEAndretti Acquisition Corp. II | Mar 2026 | $246.41M | +4.0% | — | 99.9% |
AACBArtius II Acquisition Inc. Class A Ordinary Shares | Mar 2026 | $230.14M | +4.1% | — | 99.9% |
LEGTLegato Merger Corp. III | Feb 2026 | $220.8M | +4.0% | — | 99.7% |
| Mar 2026 | $178.58M | +31057844.0% | — | 99.5% | |
| Peer median (excluding CGCT) | $247.08M | +4.1% | — | 99.7% | |
Competitors are the stored peer set for CGCT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 0 | 624.16K |
| Short-term Investments | 0 | 0 |
| Net Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Other Current Assets | 0 | 0 |
| Total Current Assets | 3.2K | 740.14K |
| Property, Plant & Equipment (Net) | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-term Investments | 0 | 283.38M |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 263.68K | 37.44K |
| Total Non-current Assets | 263.68K | 283.41M |
| Total Assets | 266.88K | 284.15M |
| Account Payables | 0 | 0 |
| Short-term Debt | 41.63K | 0 |
| Tax Payables | 0 | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | 0 | 834.87K |
| Total Current Liabilities | 284.5K | 834.87K |
| Long-term Debt | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 |
| Other Non-current Liabilities | 0 | 13.14M |
| Total Non-current Liabilities | 0 | 13.14M |
| Total Liabilities | 284.5K | 13.97M |
| Common Stock | 575 | 283.38M |
| Retained Earnings | (42.62K) | (13.2M) |
| Accumulated OCI | 0 | 0 |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 0 | 0 |
| Total Equity | (17.62K) | 270.18M |
| Total Debt | 41.63K | 0 |
| Net Debt | 41.63K | (624.16K) |
Cartesian Growth Corporation III
NASDAQ:CGCT
Intrinsic Alpha fair value
Locked
Current Price
$16.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.